Acurx Pharmaceuticals, Inc.
ACXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736243
No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Acurx Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 16 | −15 |
| SharesConverted for a 1-for-20 split | 130.5K | 7.65 | 63.4K | −67.1K (−51.4%) |
| Value | $1.33M | $0 | $241.5K | −$1.09M (−81.8%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 453 | $1.94K | 0.00% |
| Advisory Services Network, LLC | 59 | $253 | 0.00% |
| Wealthspire Advisors, LLC | 15 | $65 | 0.00% |
Sold out (18)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Armistice Capital, LLC | 1,078,540 | $550.9K |
| Geode Capital Management, LLC | 146,404 | $74.8K |
| Vanguard Group Inc | 145,537 | $74.4K |
| Renaissance Technologies LLC | 87,781 | $44.8K |
| Cambridge Investment Research Advisors, Inc. | 85,000 | $43.0K |
| O'Brien Greene & Co. Inc | 60,000 | $30.6K |
| Virtu Financial LLC | 55,126 | $28.0K |
| Vanguard Capital Wealth Advisors | 46,000 | $23.5K |
| ACT Advisors, LLC. | 45,952 | $23.5K |
| State Street Corp | 43,466 | $22.2K |
| UBS Group AG | 38,759 | $19.8K |
| XTX Topco Ltd | 37,685 | $19.2K |
| Jane Street Group, LLC | 28,024 | $14.3K |
| Northern Trust Corp | 27,286 | $13.9K |
| Wealthcare Advisory Partners LLC | 11,538 | $5.89K |
| Baader Bank INC | 16,394 | $5.17K |
| Quartz Partners, LLC | 10,000 | $5.11K |
| Simplex Trading, LLC | 6,889 | $3.00K |
Not filed for Q3 2025 yet (1)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Semmax Financial Advisors Inc. | 153 | – |